The Valley Desk

NCT01910402 · Interventional trial

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

Overall registry status Completed

Phase 3

Conditions HIV Infections, Infection, Human Immunodeficiency Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov